Related references
Note: Only part of the references are listed.Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
Grzegorz Grześk et al.
MOLECULES (2023)
Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
Lukasz Wolowiec et al.
PHARMACEUTICS (2023)
Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension
Linh Ho et al.
BIOMEDICINES (2022)
Pulmonary Hypertension in 2021: Part I-Definition, Classification, Pathophysiology, and Presentation
Theresa A. Gelzinis
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)
The Landscape of Noncoding RNA in Pulmonary Hypertension
Lin Deng et al.
BIOMOLECULES (2022)
The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension
Meng-Chien Willie Hsieh et al.
BIOMEDICINES (2022)
Pulmonary hypertension mortality trends in United States 1999-2019
Mohleen Kang et al.
ANNALS OF EPIDEMIOLOGY (2022)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
Molecular Pathways in Pulmonary Arterial Hypertension
Aangi J. Shah et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Safety of PCSK9 inhibitors
Grzegorz Grzesk et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism
Qian Wang et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2022)
Pulmonary Arterial Hypertension
Paul M. Hassoun
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
Xiaoqing Luo et al.
CELL DEATH & DISEASE (2021)
Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters
Alicja Nowaczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Current Modulation of Guanylate Cyclase Pathway Activity-Mechanism and Clinical Implications
Grzegorz Grzesk et al.
MOLECULES (2021)
Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs
Kashif Rafiq Zahid et al.
CARDIOVASCULAR RESEARCH (2020)
LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222/ING5 axis
Yan Han et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)
Pulmonary Hypertension: A Brief Guide for Clinicians
Stacy A. Mandras et al.
MAYO CLINIC PROCEEDINGS (2020)
Down-regulation of lncRNA Gas5 promotes hypoxia-induced pulmonary arterial smooth muscle cell proliferation by regulating KCNK3 expression
Xuewei Hao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Micro-RNA Analysis in Pulmonary Arterial Hypertension Current Knowledge and Challenges
Catia A. Santos-Ferreira et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Circular RNAs open a new chapter in cardiovascular biology
Simona Aufiero et al.
NATURE REVIEWS CARDIOLOGY (2019)
Past, present, and future of circRNAs
Ines Lucia Patop et al.
EMBO JOURNAL (2019)
Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension
Yan Xing et al.
MOLECULAR THERAPY (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Circular RNAs: Promising Biomarkers for Human Diseases
Zhongrong Zhang et al.
EBIOMEDICINE (2018)
LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension
Hua Su et al.
RESPIRATORY RESEARCH (2018)
mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide
Akinobu Matsumoto et al.
NATURE (2017)
Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
Zhijun Pei et al.
ONCOTARGET (2017)
Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway
Zengxian Sun et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2
Paola Caruso et al.
CIRCULATION (2017)
Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis
Hui Zhang et al.
CIRCULATION (2017)
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism
Xinping Chen et al.
CIRCULATION (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
Yehoshua Enuka et al.
NUCLEIC ACIDS RESEARCH (2016)
Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction
Melanie Vausort et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
Prakash Chelladurai et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Pulmonary hypertension in the elderly: a different disease?
Gregory Berra et al.
BREATHE (2016)
MicroRNAs in Pulmonary Arterial Hypertension
Guofei Zhou et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists
Rosalinda Madonna et al.
CARDIOVASCULAR DRUGS AND THERAPY (2015)
A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
Douglas M. Anderson et al.
CELL (2015)
Principles of miRNA-mRNA interactions: beyond sequence complementarity
Fabian Afonso-Grunz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension
Francois Potus et al.
CIRCULATION (2015)
Long Noncoding RNAs in Cardiovascular Diseases
Shizuka Uchida et al.
CIRCULATION RESEARCH (2015)
Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension
Jun-Dae Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Impaired Angiogenesis and Peripheral Muscle Microcirculation Loss Contribute to Exercise Intolerance in Pulmonary Arterial Hypertension
Francois Potus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Therapeutic implications of microRNAs in pulmonary arterial hypertension
Aram Lee et al.
BMB REPORTS (2014)
MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts
Daren Wang et al.
CIRCULATION RESEARCH (2014)
Competing Endogenous RNA: The Key to Posttranscriptional Regulation
Rituparno Sen et al.
SCIENTIFIC WORLD JOURNAL (2014)
Pulmonary Arterial Hypertension in Adults: Novel Drugs and Catheter Ablation Techniques Show Promise? Systematic Review on Pharmacotherapy and Interventional Strategies
Salvatore Rosanio et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Structure and function of long noncoding RNAs in epigenetic regulation
Tim R. Mercer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension
Changjin Lee et al.
CIRCULATION (2012)
The MicroRNA-328 Regulates Hypoxic Pulmonary Hypertension by Targeting at Insulin Growth Factor 1 Receptor and L-Type Calcium Channel-α1C
Lei Guo et al.
HYPERTENSION (2012)
Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression
Clemens L. Bockmeyer et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
Julia Salzman et al.
PLOS ONE (2012)
Plexiform Lesions in Pulmonary Arterial Hypertension Composition, Architecture, and Microenvironment
Danny Jonigk et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Epigenetics: Principles and Practice
James P. Hamilton
DIGESTIVE DISEASES (2011)
Role for miR-204 in human pulmonary arterial hypertension
Audrey Courboulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Pulmonary hypertension: advances in pathogenesis and treatment
M. Toshner et al.
BRITISH MEDICAL BULLETIN (2010)
Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension A Basis for Excessive Cell Proliferation and a New Therapeutic Target
Stephen L. Archer et al.
CIRCULATION (2010)
Cardiovascular Epigenetics Basic Concepts and Results From Animal and Human Studies
Andrea Baccarelli et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway
Matthias Brock et al.
CIRCULATION RESEARCH (2009)
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females
E. D. Austin et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)